SCHOTT to invest in China

Groundbreaking ceremony: New pharmaceutical packaging plant to open in 2017 / further investments to be made in integrated site in Suzhou.   The German technology group SCHOTT AG is looking to extend its presence in the Asian growth market.

This week, the company has laid the cornerstone for another pharmaceutical packaging plant that will be located south of Shanghai. Starting in 2017, glass packaging for injectable drugs will be manufactured here, in particular vials and ampoules. Furthermore, the SCHOTT Group also plans to modernize and expand its existing facilities at its integrated site in Suzhou. The Pharmaceutical Systems division of SCHOTT will invest approx. EUR 30 million in total in China over the next three years. These measures will increase the company’s production capacity by 50 per cent over the same period.

With this expansion, the company is paying tribute to the strong growth of the Chinese pharmaceutical market. SCHOTT serves this market from two production facilities – a plant in Suzhou, which is an integrated production facility of the SCHOTT Group, and through its joint venture, Zhejiang Xinkang Pharmaceutical Glass Co. The new production facility will be built at the site of Xinkang’s headquarters in Jinyun.

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products. SCHOTT is an innovative enabler for many industries, including the home appliance, pharmaceutical, electronics, optics, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 35 countries. With its workforce of approximately 15,400 employees, sales of 1.87 billion euros were generated in fiscal year 2013/2014. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. www.schott.com

600450 SCHOTT to invest in China glassonweb.com

See more news about:

Others also read

SCHOTT is introducing a new, innovative portfolio of structured glass substrates that offers highly accurate and versatile features: FLEXINITY™. Credit: SCHOTT
SCHOTT is introducing a new, innovative portfolio of structured glass substrates that offers highly accurate and versatile features: FLEXINITY™.
Cold bending makes it possible to place curvatures on glass immediately before installation. (Photo credit: Lisec Austria GmbH)
Thin glass is revolutionising the performance spectrum of glass and glass panes.
CONTURAN® IR Protect deflects infrared (IR) and ultraviolet (UV) radiation with a high degree of success. Picture: SCHOTT AG.
The latest laminated, anti-glare cover glass from SCHOTT – CONTURAN® IR Protect – deflects more than 80 percent of infrared (IR) and ultraviolet (UV) radiation.
Exceptional quality and safety standards are hallmarks of the production at SCHOTT Gemtron´s flat glass plant in San Luis Potosi. Photo: SCHOTT
A quarter of a century ago, the German technology group SCHOTT followed a customer to San Luis Potosí, and a Latin American success story began
The ultra-thin glass from SCHOTT is not only convincing under laboratory conditions, but also when utilized as a protective display for smartphones, where it responds reliably to the daily challenges the devices are constantly confronted with.
Ultra-thin smartphone protective glass from SCHOTT now available in retail.
SCHOTT’s Opportunity Lab addresses current and potential customers who are looking for solutions for their ideas and projects. Glass with its various properties could be just the suitable material they need.
SCHOTT technology group opens its “Opportunity Lab” to the public for fresh ideas.

Add new comment